DIPEXIUM PHARMACEUTICALS INC - COM (DPRX)

CUSIP: 25456J104

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
1,593,478
Share change
+40,851
Total reported value
$21,732,000
Price per share
$13.64
Number of holders
19
Value change
+$727,903
Number of buys
13
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 25456J104?
CUSIP 25456J104 identifies DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) as of Q1 2015

As of 31 Mar 2015, DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,593,478 shares. The largest 10 holders included KINGDON CAPITAL MANAGEMENT, L.L.C., Broadfin Capital, LLC, Timpani Capital Management LLC, VANGUARD GROUP INC, ARDSLEY ADVISORY PARTNERS, OPPENHEIMER & CO INC, PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Spark Investment Management LLC, and STONERIDGE INVESTMENT PARTNERS LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.